Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment
Medulloblastoma (MB) is the most common malignant central nervous system tumor in pediatric patients.Mainstay of therapy remains surgical resection followed by craniospinal radiation and chemotherapy, although limitations to this therapy are applied in the youngest patients.Clinically, tumors are divided into average and Liners high-risk status on